newsfilter
← Latest News
PR Newswire·

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

LONDON and DUBAI, UAE , June 14, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the detection of immune responses